by Feldan, on Nov 27, 2018 8:41:10 AM
Québec City, Canada, November 27, 2018 – Feldan Therapeutics (hereafter “Feldan”), a preclinical biotechnology company specialized in the intracellular delivery of therapeutic proteins and peptides, has announced an investment of …
Read Storyby feldan_client, on Nov 14, 2018 9:57:08 AM
We are proud partner of the CRISPR congress 2019 to be held in Québec City, June 17-20, 2019. This annual event provides an international forum for scientists and organizations interested …
Read Story
2666, Boul. du Parc Technologique Suite 290
Quebec, Qc, Canada,
G1P 4S6
Phone: 1-418-872-7277
Email: info@feldan.com